BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95 Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R , |
|
|
Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 103 Issue 23-24 Pages: 9673-9686 Pub: 2019 Dec Epub: 2019 Nov 12 Authors Wang Q , Lv L , Jiang H , Wang K , Yan R , Li Y , Ye J , Wu J , Wang Q , Bian X , Yang L , Jiang X , Xie J , Lu Y , Shen J , Li L , |
|
|
Comparative Evaluation of the Inhibitory Effect of Lactobacillus rhamnosus on Halitosis-Causing Bacteria: An Invitro Microbiological Study. ✅
Go to Publication ✅
Cureus (Cureus ) Vol: 15 Issue 5 Pages: e38568 Pub: 2023 May Epub: 2023 May 5 Authors Patil AV , Shetty SS , Padhye AM , |
|
|
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 15460 Pub: 2024 Jul 4 Epub: 2024 Jul 4 Authors Aktas B , Aslim B , Ozdemir DA , |
|
|
Lactobacillus sp. improved microbiota and metabolite profiles of aging rats. ✅
Go to Publication ✅
Pharmacological research (Pharmacol Res ) Vol: 146 Issue Pages: 104312 Pub: 2019 Aug Epub: 2019 Jun 14 Authors Hor YY , Lew LC , Jaafar MH , Lau AS , Ong JS , Kato T , Nakanishi Y , Azzam G , Azlan A , Ohno H , Liong MT , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice. ✅
Go to Publication ✅
Nature communications (Nat Commun ) Vol: 9 Issue 1 Pages: 2802 Pub: 2018 Jul 18 Epub: 2018 Jul 18 Authors Natividad JM , Lamas B , Pham HP , Michel ML , Rainteau D , Bridonneau C , da Costa G , van Hylckama Vlieg J , Sovran B , Chamignon C , Planchais J , Richard ML , Langella P , Veiga P , Sokol H , |
|
|
Lactobacillus helveticus LZ-R-5 Ameliorates DSS-Induced Colitis in Mice by Modulating Gut Microbiota and Enhancing Intestinal Barrier Function. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 73 Issue 1 Pages: 464-477 Pub: 2025 Jan 8 Epub: 2024 Dec 17 Authors Zhao X , Lin T , Jiang W , Lin Y , Xiao L , Tian Y , Ma K , Zhang C , Ji F , Mahsa GC , Rui X , Li W , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
